MIRA
INFORM REPORT
|
Report Date : |
20.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
RAZAK PHARMACEUTICAL LABORATORIES CO |
|
|
|
|
Registered Office : |
KM 10 Karaj Makhsoos Road, Tehran |
|
|
|
|
Country : |
Iran |
|
|
|
|
Date of Incorporation : |
15.06.1964 |
|
|
|
|
Com. Reg. No.: |
9593 |
|
|
|
|
Legal Form : |
Public Joint
Stock Company |
|
|
|
|
Line of Business : |
Manufactures Medicinal Chemicals and Botanical Products. |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Company
Details
Company Name: Razak
Pharmaceutical Laboratories Co
Headquarter Address: KM 10 Karaj
Makhsoos Road, Tehran , Iran
P O BOX: 13185-1671 Tehran
Iran
Tel: +98 2144452419
+98 2144452420
+98 2144525411
+98 2144525412
+98 2144525413
+98 2144525414
+98 2144525415
+98 2144525416
+98 2144525417
Fax: +98 21 44525410
Website: www.razak-labs.com
E-mail: razak@razak-labs.com
History
The company was founded in 1964 as a subsidiary of
pfizer international and went into production in 1967. After the Islamic
Revolution, it was nationalized and the name changed to Razak laboratories.
Registration
& Legal Details
Current Legal Form: Public Joint Stock Company
Registration Address: KM 10 Karaj Makhsoos Road, Tehran , Iran
Registration Number: 9593
Registration Date: 15 June 1964
Start Date: 15 June 1964
Registration Town: Tehran
Capital
Nominal capital: 41,000,000,000 Iranian
Rials
Shares Number: 41.000.000.000
Share Value: 1,000 Iranian Rials
Shareholders
|
Shareholder Names |
Share% |
|
Daroupakhsh Co |
55 |
|
Melli Bank Investing Management Co |
12 |
|
Tejarat Bank Staff Co |
2 |
|
Saba Tamein Investment Co |
2 |
|
Asia Insurance Co |
2 |
|
Bou Ali Investment Co |
1 |
|
Tadbir Investment Co |
1 |
|
Others |
1 |
Principals
Name: Mr. Mohammad Ali Salem
Position within the company: Chairman
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi- English
Name: Mr.
Alireza Mohammadi Rad
Position within the company: Vice- Chairman
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi,
English
Name: Mr. Mansour Samiei
Position within the company: Member, Managing Director
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi,
English
Name: Mr. Gholam Hussien Asgari
Position within the company: Member
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi
Name: Mr. Afshin Zarghi
Position within the company: Member
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi
Name: Mrs. Sanaz Tabatabaie
Position within the company: Secretary
Country of Birth: Iran
Nationality: Iranian
Can fluently speak: Farsi
Company
Activities
It manufactures medicinal chemicals and botanical products.
Certificated: ISO9002 and ISO14001 and
ISO18001
Operations
Employees
Company Employs: 750
HQ Premises
Operates from: Owned Office, Warehouse,
Factory
Location: Central Business Area,
Main Road
Imports
Imports: Finished Goods
Import%:
10%
Import from: Europe
Import terms: letters of credit
Additional:
balance of 90% purchased via local market
Export
Exports: Finished Good
Export%: 20
%
Export from: Iraq, Lebanon , Syria
Export terms: letters of credit
Trading
& Selling
Territory: 80 %
Nationality –20% Internationally
Type of Customer: General Public, Local
Authorities
Terms of sales: Cash, letters of credit
Vehicles: Total number of vehicles:45
Related
Companies
Competitors:
Pars Darou Public Joint Stock Co
Iran
Cosar Pharmaceutical Co
Iran
Banks
Melli Bank
Tehran
Iran
Financial
Information
Source:
Mrs. Sanaz Tabatabaie
Currency: Iranian Rials
Note:
Figures in 000,000
|
Months |
Sales figures |
Sales |
Gross profit/loss |
Net profit/loss |
|
12 |
29/03/2007 |
388,224 |
110,767 |
67,062 |
BALANCE SHEET
Source:
Financial Estimates in 2007
Currency: Iranian Rials
Note:
Figures in 000,000
|
NEW WORTH |
26,940 |
|
Trade Creditor |
95,060 |
|
Total Liabilities |
385,374 |
|
|
|
|
Trade Debtors |
67,650 |
|
Total Assets |
439,724 |
Payments
Subject's payments reported to be: NO COMPLAINTS
Representative
Solicitor: Daya Raya Co
Auditor: Mr. Gholam Hussien Davani
interview
& reporter comments
Name/Title: Mrs. Sanaz Tabatabaie ( Secretary )
In the interview conducted with Mrs. Sanaz Tabatabaie ( Secretary )she declined
bank account numbers and full financial
information citing the grounds of Company confidentiality.
Conclusion
Local Reputation: The company being investigated is considered by local reporters to be a
Medium Trade Risk
and to be fair, the company is a known
on Iran market.
Owner/Shareholders Comments:
Some of owners involved in the running of
the business
Age of Business: Old
Business
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)